By Topic

Nonautologous gene therapy with implantable devices

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

1 Author(s)
P. L. Chang ; Dept. of Pediatrics, Biomed. Sci. & Biol., McMaster Univ., Hamilton, Ont., Canada

Treatment of human diseases with gene therapy is a technological break through that has been touted to be the "ultimate medicine". A potentially more cost-effective method of gene therapy is to use universal cell lines engineered to secrete therapeutic products that are suitable for implantation in all patients requiring the same product replacement. To avoid immune rejection, these nonautologous donor cells can be protected within immuno-isolation devices such as alginate-fabricated microcapsules. This article documents the early development and current status of nonautologous somatic gene therapy, combining biomaterial with genetic engineering to develop a new direction of research. Topics covered include: questions in gene therapy; nonautologous somatic gene therapeutics; the expression of recombinant gene products in immuno-isolation devices; the delivery of recombinant gene products with encapsulated cells in vivo; and animal models of human genetic diseases.

Published in:

IEEE Engineering in Medicine and Biology Magazine  (Volume:16 ,  Issue: 5 )